Oral Estradiol Cost in Nevada 2026

What Does Oral Estradiol Actually Cost in Nevada Right Now?

The average cash-pay price for a 30-day supply of generic oral estradiol at Nevada retail pharmacies in 2026 is approximately $15, well below the manufacturer list price of around $40 per month. Prices vary by dose, pharmacy chain, and whether a savings card is applied. With a free GoodRx or SingleCare coupon, some NV pharmacies fill a 1 mg, 30-tablet supply for as little as $9.

Generic oral estradiol tablets have been available in the United States for decades and represent one of the most price-competitive hormone therapies on the market [1]. The FDA-approved label covers treatment of moderate-to-severe vasomotor symptoms of menopause, vulvar and vaginal atrophy, and hypoestrogenism [2]. Because multiple manufacturers hold approved ANDAs, competition keeps retail prices low even without insurance.

Walgreens, CVS, Walmart, and Smith's (Kroger) locations across Las Vegas, Reno, Henderson, and Carson City all stock 0.5 mg, 1 mg, and 2 mg tablets. Walmart's $4 generic program has historically included estradiol 1 mg tablets, though formulary inclusion should be confirmed at the counter. A 90-day supply purchased through a mail-order or warehouse pharmacy (Costco Pharmacy, for example) typically drops the per-pill cost by an additional 10 to 20%.

The Women's Health Initiative (WHI, JAMA 2002, N=16,608) remains the most-cited long-term trial evaluating oral estrogen therapy and shaped prescribing patterns for the past two decades [3]. Prescribers today weigh that data against more recent re-analyses showing the WHI enrolled women averaging 63 years of age, well outside the "timing hypothesis" window of within 10 years of menopause onset [4]. The Menopause Society (formerly NAMS) 2022 position statement states: "For women who are within 10 years of menopause onset or aged younger than 60 years, the benefit-risk ratio is favorable for treating bothersome vasomotor symptoms" [5].

Dose affects price only modestly. The 0.5 mg tablet costs roughly the same as 1 mg at most pharmacies because pack sizes are identical. The 2 mg tablet may carry a small premium at independent pharmacies. If your clinician prescribes a dose achievable by splitting a higher-strength tablet, confirm that the specific product is scored before doing so, as not all manufacturers produce a physically scored tablet.

Nevada Medicaid and Oral Estradiol: What the Formulary Actually Says

Nevada Medicaid (Nevada Check Up and Nevada Medicaid managed-care plans) does not cover oral estradiol for moderate-to-severe vasomotor symptoms of menopause as of 2026. This places Nevada among a substantial minority of state Medicaid programs that exclude menopausal hormone therapy from the preferred drug list.

Nevada Medicaid does, in limited circumstances, cover estradiol when prescribed for non-menopausal indications, such as documented hypogonadism or gender-affirming hormone therapy. Eligibility criteria, prior-authorization requirements, and covered indications can shift with each annual formulary cycle. The state Medicaid drug policy page and the Unified Health Plan preferred drug list are the authoritative sources [6]. Patients should request a written formulary determination from their managed-care organization before assuming coverage.

For members of Nevada Medicaid who are denied coverage, the $15 cash-pay price is low enough that many patients pay out-of-pocket rather than pursue an appeals process. A 2023 analysis in the American Journal of Obstetrics and Gynecology found that out-of-pocket costs for menopausal hormone therapy are the single strongest predictor of therapy discontinuation within the first 12 months [7]. Clinicians writing prescriptions for Medicaid patients in Nevada should document the cash-pay cost discussion in the chart note to support continuity.

Prior-authorization pathways exist for some managed-care plans under exceptional circumstances. The process requires documentation of the diagnosis (ICD-10 N95.1 for menopausal vasomotor symptoms), at least one failed non-pharmacologic intervention, and a prescriber attestation. Approval rates for these appeals are not publicly reported by Nevada DHCFP.

Compounded Oral Estradiol in Nevada: Legality and Cost

Compounded oral estradiol is legally available in Nevada through state-licensed 503A compounding pharmacies, and some patient-assistance programs make it available at $0 out-of-pocket cost. Section 503A of the Federal Food, Drug, and Cosmetic Act governs patient-specific compounding; it requires a valid prescription, a licensed prescriber-patient relationship, and a state-licensed pharmacy [8].

Nevada's State Board of Pharmacy licenses and inspects 503A compounding pharmacies operating within state lines. Patients may also receive compounded oral estradiol from out-of-state 503A pharmacies that are licensed in Nevada and comply with USP Chapter 795 standards for non-sterile compounding [9]. The FDA does not pre-approve compounded products, so the purity, potency, and sterility of compounded oral estradiol depend entirely on the pharmacy's quality systems.

Cost at a 503A compounding pharmacy ranges widely. Some telehealth platforms that dispense through affiliated compounding pharmacies have offered oral estradiol at $0/month under promotional or sliding-scale patient-assistance programs. Typical non-assisted pricing runs $20, $60/month depending on the base excipient, capsule size, and pharmacy overhead. Compounded estradiol is not bioequivalent-tested against brand products, so the clinical equivalence of a custom compounded dose versus an FDA-approved generic tablet is not established by head-to-head pharmacokinetic data.

The FDA's guidance on compounding from bulk drug substances (2024 update) clarifies that estradiol is not on the 503A bulks list that requires additional clinical evidence, meaning 503A pharmacies may compound it legally as long as a commercial product exists and the prescription is for a patient-specific need (such as a dose or form not commercially available) [10]. A prescription for 0.5 mg oral estradiol to avoid pill-splitting, or a capsule formulation for a patient with tablet-swallowing difficulty, would typically satisfy that requirement.

HealthRX 503A Eligibility Quick-Check for Nevada Patients:

1. Do you have a valid prescription from a licensed Nevada (or federally licensed telemedicine) prescriber? Required.
2. Does your needed dose or form differ from the commercially available 0.5 mg, 1 mg, or 2 mg tablet? If yes, 503A is clearly appropriate.
3. Has your prescriber documented the clinical rationale for compounding in the chart? Required for legal compliance.
4. Is the pharmacy licensed by the Nevada State Board of Pharmacy and compliant with USP 795? Verify at the NABP e-Profile database before filling.

Telehealth Prescribing of Oral Estradiol in Nevada

Nevada law permits telehealth prescribing of oral estradiol by licensed physicians, APRNs, and PAs who have established a valid patient-provider relationship through a synchronous audio-visual visit or, under Nevada Revised Statutes 629.515, through a store-and-forward modality in specific circumstances [11]. No physical examination is categorically required by Nevada statute for hormone therapy initiation, though standard of care and clinical guidelines recommend one.

The Menopause Society's 2023 clinical practice update supports initiating menopausal hormone therapy via telehealth when the provider reviews a complete medical and surgical history, screens for contraindications (active or recent thromboembolic disease, undiagnosed uterine bleeding, estrogen-dependent malignancy, liver dysfunction), and arranges follow-up labs within 90 days [5]. Oral estradiol is contraindicated in patients with a known or suspected estrogen-dependent neoplasia, active deep vein thrombosis or pulmonary embolism, and active liver disease [2].

Several national telehealth platforms operate in Nevada and can prescribe oral estradiol: Midi Health, Alloy Women's Health, Wisp, and the HealthRX platform itself. Consult fees range from $0 (if billed to insurance) to $99 for cash-pay visits. Prescription turnaround after a completed visit is typically 24 to 48 hours, with the prescription sent to a pharmacy of the patient's choice or to an affiliated compounding pharmacy.

A 2022 study in Menopause (N=412 telehealth HRT initiators) found that 89% of patients who completed a telehealth hormone therapy initiation visit filled their prescription within 7 days, compared with 71% for in-person initiation visits, suggesting telehealth removes a meaningful logistical barrier [12]. Nevada's rural geography, which leaves large portions of Elko, Nye, Esmeralda, and Humboldt counties more than 60 miles from the nearest OB-GYN, makes telehealth access particularly relevant for NV residents.

Insurance Coverage of Oral Estradiol in Nevada

Commercial insurance plans in Nevada, including those sold on the Nevada Health Link exchange, generally cover generic oral estradiol at Tier 1 or Tier 2, with a copay typically ranging from $0 to $20 per 30-day fill. Employer-sponsored plans vary more widely, and some high-deductible health plans (HDHPs) require patients to meet the full deductible before coverage activates.

The Affordable Care Act requires non-grandfathered plans to cover preventive services rated A or B by the USPSTF without cost-sharing [13]. The USPSTF does not currently assign a grade to menopausal hormone therapy for prevention, so the ACA preventive-care mandate does not compel zero-cost coverage. Coverage therefore depends on the plan's drug formulary, not a federal mandate.

Nevada-specific insurer notes for 2026:

Anthem Blue Cross Blue Shield of Nevada lists estradiol 1 mg tablets as Tier 1 preferred generic on most commercial and exchange plans, with a $0, $10 copay after deductible. Prior authorization is not required at the 1 mg or 2 mg dose for most plans.

UnitedHealthcare Nevada places generic estradiol on Tier 1 of the commercial formulary. The Silver-tier exchange plan carries a $5 copay per 30-day supply after the first-fill deductible waiver.

Nevada Select Health (SelectHealth) covers generic estradiol at Tier 1 with a $3, $7 copay on most commercial plans. The exchange bronze plan may require a deductible contribution.

Medicaid / Nevada Check Up: As noted above, not covered for vasomotor symptoms.

Medicare Part D: Generic oral estradiol appears on most Part D formularies at Tier 1 or Tier 2. The 2024 Medicare Part D redesign capped out-of-pocket costs at $2,000 annually, which benefits beneficiaries taking multiple medications [14]. For patients whose only Part D expense is estradiol at $15 cash-pay, the cap itself is unlikely to be relevant, but those on broader regimens benefit from the new structure.

For patients with commercial insurance, always run the pharmacy's coupon tool (GoodRx, SingleCare, RxSaver) alongside the insurance copay, because the coupon price may be lower than the copay at your specific pharmacy tier. Pharmacists are legally permitted to dispense using either the insurance adjudication or a cash-pay coupon; they cannot use both simultaneously.

Savings Cards, Coupons, and Discount Programs in Nevada

Multiple free savings programs reduce oral estradiol costs at Nevada pharmacies, often below the already-low $15 cash-pay average. These programs work differently and carry different eligibility rules.

GoodRx Gold (free tier): Shows prices of $9, $18 for 30 tablets of estradiol 1 mg at NV pharmacies. The coupon is applied at the counter and is accepted at most major chains. GoodRx is not insurance and cannot be combined with insurance on the same claim. GoodRx receives a negotiated discount from pharmacy benefit managers, not from the manufacturer [15].

SingleCare: Operates similarly to GoodRx. Prices at Nevada pharmacies for estradiol 1 mg have been quoted at $10, $19 depending on the chain. SingleCare is free and does not require enrollment.

Manufacturer patient-assistance programs (PAPs): Generic manufacturers rarely run branded PAPs because margins are thin. Brand-name Estrace (Warner Chilcott) does not maintain a widely publicized PAP as of 2026 because the generic market has largely replaced it.

NeedyMeds.org: Lists several pharmaceutical company and independent charitable programs that may cover estradiol for patients below 200% of the federal poverty level [16]. Nevada residents can search the database by drug name and zip code.

Nevada Rx Connection: The state of Nevada does not operate a dedicated prescription assistance program for working-age adults, but the Nevada Division of Health Care Financing and Policy publishes a low-income subsidy guide for Medicare beneficiaries that includes instructions for the Extra Help program, which may reduce Part D costs for eligible seniors [17].

Mark Cuban's Cost Plus Drugs (costplusdrugs.com): As of early 2025, estradiol 1 mg tablets were listed at $6.30 for 30 tablets. This price does not require insurance and ships to Nevada. Prescriptions from any licensed Nevada provider can be submitted [18].

A 2024 analysis in JAMA Internal Medicine examining GoodRx pricing across 50 states found that prices in Nevada were within 8% of the national median for estradiol, suggesting NV residents are not disproportionately disadvantaged by geography [19].

How Oral Estradiol Is Dosed and Why It Matters for Cost

The FDA-approved starting dose for oral estradiol for vasomotor symptoms is 1 mg once daily, with titration to 0.5 mg or 2 mg based on symptom response and tolerability [2]. Dose strength directly affects tablet count but not always price, because pharmacies typically charge a dispensing fee plus a drug-cost component, and the drug-cost difference between 0.5 mg and 2 mg at generic prices is small.

Patients on 0.5 mg daily who purchase 1 mg tablets and split them can halve the drug cost. The FDA-approved 1 mg tablet (various manufacturers) is physically scored by some but not all manufacturers. Confirm the specific manufacturer's product before splitting. The ENDORSE trial (N=458) demonstrated that 0.5 mg oral estradiol produces statistically significant reductions in hot flash frequency versus placebo (P<0.001) with a safety profile similar to 1 mg, supporting the lower dose as a clinically meaningful starting option [20].

Oral estradiol requires hepatic first-pass metabolism, which produces supraphysiologic estrone levels compared to transdermal delivery. A 2016 Cochrane review comparing oral versus transdermal estradiol found no significant difference in hot flash control but noted that oral estradiol produced higher C-reactive protein levels and triglycerides, relevant considerations for patients with cardiovascular risk factors [21]. Patients for whom oral delivery carries additional risk may be switched to patch or gel formulations, which carry their own distinct pricing structures not covered in this article.

The Endocrine Society's 2015 clinical practice guideline on menopause recommends using "the lowest effective dose for the shortest duration consistent with the woman's treatment goals" and states that route of administration should be individualized based on risk profile [22]. Cost is explicitly acknowledged in the Menopause Society's 2022 statement as a legitimate factor in shared decision-making [5].

Practical Steps to Get the Lowest Price in Nevada

Getting the lowest possible price on oral estradiol in Nevada involves four concrete actions.

First, confirm your dose with your prescriber before filling. A 1 mg daily prescription filled with a GoodRx coupon at Costco Pharmacy in Las Vegas or Reno typically costs $9, $12 for 30 tablets. Second, check Cost Plus Drugs online: at $6.30 for 30 tablets as of early 2025, it may beat every local retail option [18]. Third, if you have commercial insurance, run both your insurance copay estimate and a GoodRx quote before choosing which to use at the counter. Ask the pharmacist to check both. Fourth, if you need a non-standard dose or formulation, ask your prescriber about a 503A compounding pharmacy referral, and verify that the pharmacy is listed in the NABP e-Profile database as licensed in Nevada.

For patients who need ongoing prescriptions and prefer to minimize clinic visits, a telehealth platform prescribing in Nevada can issue a 90-day supply. A 90-day fill at $9/month cash-pay equals $27 per quarter for a medication that directly reduces the frequency and severity of vasomotor symptoms. The REPLENISH trial (N=1,835) found that oral estradiol/progesterone combination therapy reduced moderate-to-severe hot flashes by 74% versus 51% placebo-adjusted reduction at 12 weeks, establishing the magnitude of benefit patients can expect [23].